BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Treister R, Honigman L, Lawal OD, Lanier RK, Katz NP. A deeper look at pain variability and its relationship with the placebo response: results from a randomized, double-blind, placebo-controlled clinical trial of naproxen in osteoarthritis of the knee. Pain 2019;160:1522-8. [PMID: 30817436 DOI: 10.1097/j.pain.0000000000001538] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 13.0] [Reference Citation Analysis]
Number Citing Articles
1 Canaipa R, Khallouf A, Magalhães AR, Teodoro R, Pão-mole V, Agostinho M, Pimentel-santos F, Honigman L, Treister R. Relations between short-term memory and the within-subject variability of experimental pain intensity reports: Results from healthy and Fibromyalgia patients. PLoS ONE 2022;17:e0277402. [DOI: 10.1371/journal.pone.0277402] [Reference Citation Analysis]
2 Edwards RR, Schreiber KL, Dworkin RH, Turk DC, Baron R, Freeman R, Jensen TS, Latremoliere A, Markman JD, Rice AS, Rowbotham M, Staud R, Tate S, Woolf CJ, Andrews NA, Carr DB, Colloca L, Cosma-roman D, Cowan P, Diatchenko L, Farrar J, Gewandter JS, Gilron I, Kerns RD, Marchand S, Niebler G, Patel KV, Simon LS, Tockarshewsky T, Vanhove GF, Vardeh D, Walco GA, Wasan AD, Wesselmann U. Optimizing and Accelerating the Development of Precision Pain Treatments for Chronic Pain: IMMPACT Review and Recommendations. The Journal of Pain 2022. [DOI: 10.1016/j.jpain.2022.08.010] [Reference Citation Analysis]
3 Henriksen M, Nielsen SM, Christensen R, Kristensen LE, Bliddal H, Bartholdy C, Boesen M, Ellegaard K, Hunter DJ, Altman R, Bandak E. Who are likely to benefit from the Good Life with osteoArthritis in Denmark (GLAD) exercise and education program? An effect modifier analysis of a randomised controlled trial. Osteoarthritis Cartilage 2022:S1063-4584(22)00837-8. [PMID: 36089229 DOI: 10.1016/j.joca.2022.09.001] [Reference Citation Analysis]
4 Schnitzer TJ, Bonfanti G, Atkinson J, Donevan S, Viktrup L, Barroso J, Whalen E, Edwards RA. Characterizing 16-Week Responder Profiles Using Group-Based Trajectory Modeling in Over 4300 Clinical Trial Participants Receiving Pharmaceutical Treatment for Moderate to Severe Osteoarthritis. Adv Ther 2022. [PMID: 35960482 DOI: 10.1007/s12325-022-02290-3] [Reference Citation Analysis]
5 Rogers AH, Zvolensky MJ, Vujanovic AA, Ruggero CJ, Oltmanns J, Waszczuk MA, Luft BJ, Kotov R. Anxiety sensitivity and Pain Experience: a prospective investigation among World Trade Center Responders. J Behav Med 2022. [PMID: 35715542 DOI: 10.1007/s10865-022-00336-z] [Reference Citation Analysis]
6 Tiwari SR, Vigotsky AD, Apkarian AV. On the Relationship Between Pain Variability and Relief in Randomized Clinical Trials. Front Pain Res 2022;3:844309. [DOI: 10.3389/fpain.2022.844309] [Reference Citation Analysis]
7 Alcántara Montero A, Pacheco de Vasconcelos SR, Hernández Alvarado PM, Peñato Tarifa F, Matsuki Martín de Prado MT. Presente y futuras perspectivas en el abordaje farmacológico del dolor neuropático. MPJ 2022. [DOI: 10.20986/mpj.2022.1019/2021] [Reference Citation Analysis]
8 Dório M, Pereira RMR, Luz AGB, Deveza LA, de Oliveira RM, Fuller R. Efficacy of platelet-rich plasma and plasma for symptomatic treatment of knee osteoarthritis: a double-blinded placebo-controlled randomized clinical trial. BMC Musculoskelet Disord 2021;22:822. [PMID: 34560869 DOI: 10.1186/s12891-021-04706-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
9 Erpelding N, Evans K, Lanier RK, Elder H, Katz NP. Placebo Response Reduction and Accurate Pain Reporting Training Reduces Placebo Responses in a Clinical Trial on Chronic Low Back Pain: Results From a Comparison to the Literature. Clin J Pain 2020;36:950-4. [PMID: 32841968 DOI: 10.1097/AJP.0000000000000873] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
10 Evans K, Colloca L, Pecina M, Katz N. What can be done to control the placebo response in clinical trials? A narrative review. Contemp Clin Trials 2021;107:106503. [PMID: 34237458 DOI: 10.1016/j.cct.2021.106503] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
11 Katz N, Dworkin RH, North R, Thomson S, Eldabe S, Hayek SM, Kopell BH, Markman J, Rezai A, Taylor RS, Turk DC, Buchser E, Fields H, Fiore G, Ferguson M, Gewandter J, Hilker C, Jain R, Leitner A, Loeser J, McNicol E, Nurmikko T, Shipley J, Singh R, Trescot A, van Dongen R, Venkatesan L. Research design considerations for randomized controlled trials of spinal cord stimulation for pain: Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials/Institute of Neuromodulation/International Neuromodulation Society recommendations. Pain 2021;162:1935-56. [PMID: 33470748 DOI: 10.1097/j.pain.0000000000002204] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 12.0] [Reference Citation Analysis]
12 Obbarius A, Schneider S, Stone AA. A combination of pain indices based on momentary assessments can predict placebo response in patients with fibromyalgia syndrome. Pain 2021;162:543-51. [PMID: 32773601 DOI: 10.1097/j.pain.0000000000002025] [Reference Citation Analysis]
13 Stone AA, Obbarius A, Junghaenel DU, Wen CKF, Schneider S. High-resolution, field approaches for assessing pain: Ecological Momentary Assessment. Pain 2021;162:4-9. [PMID: 32833794 DOI: 10.1097/j.pain.0000000000002049] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
14 Smith SM, Fava M, Jensen MP, Mbowe OB, McDermott MP, Turk DC, Dworkin RH. John D. Loeser Award Lecture: Size does matter, but it isn't everything: the challenge of modest treatment effects in chronic pain clinical trials. Pain 2020;161 Suppl 1:S3-S13. [PMID: 33090735 DOI: 10.1097/j.pain.0000000000001849] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
15 Katz N. Design and conduct of confirmatory chronic pain clinical trials. Pain Rep 2021;6:e845. [PMID: 33511323 DOI: 10.1097/PR9.0000000000000854] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
16 Alexander RC, Raudibaugh K, Spierings ELH, Katz N. A 3-way Cross-over Study of Pregabalin, Placebo, and the Histamine 3 Receptor Inverse Agonist AZD5213 in Combination With Pregabalin in Patients With Painful Diabetic Neuropathy and Good Pain-reporting Ability. Clin J Pain 2021;37:38-42. [PMID: 33086238 DOI: 10.1097/AJP.0000000000000886] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Bihlet AR, Byrjalsen I, Simon LS, Carrara D, Delpy L, Derne C. A novel diclofenac gel (AMZ001) applied once or twice daily in subjects with painful knee osteoarthritis: A randomized, placebo-controlled clinical trial. Semin Arthritis Rheum 2020;50:1203-13. [PMID: 33059293 DOI: 10.1016/j.semarthrit.2020.09.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
18 Evans K, Romero H, Spierings EL, Katz N. The relation between the placebo response, observed treatment effect, and failure to meet primary endpoint: A systematic review of clinical trials of preventative pharmacological migraine treatments. Cephalalgia 2021;41:247-55. [PMID: 32960658 DOI: 10.1177/0333102420960020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
19 Canaipa R, Mendonça D, Agostinho M, Nascimento V, Honigman L, Treister R. En Pointe: Dancers Report Their Pain Less Variably Than Do Controls. J Pain 2021;22:97-105. [PMID: 32702405 DOI: 10.1016/j.jpain.2020.06.005] [Reference Citation Analysis]
20 Kaptchuk TJ, Hemond CC, Miller FG. Placebos in chronic pain: evidence, theory, ethics, and use in clinical practice. BMJ 2020;370:m1668. [PMID: 32690477 DOI: 10.1136/bmj.m1668] [Cited by in Crossref: 47] [Cited by in F6Publishing: 52] [Article Influence: 23.5] [Reference Citation Analysis]
21 Siracusa R, Impellizzeri D, Cordaro M, Peritore AF, Gugliandolo E, D’amico R, Fusco R, Crupi R, Rizzarelli E, Cuzzocrea S, Vaccaro S, Pulicetta M, Greco V, Sciuto S, Schiavinato A, Messina L, Di Paola R. The Protective Effect of New Carnosine-Hyaluronic Acid Conjugate on the Inflammation and Cartilage Degradation in the Experimental Model of Osteoarthritis. Applied Sciences 2020;10:1324. [DOI: 10.3390/app10041324] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
22 Gewandter JS, Dworkin RH, Turk DC, Devine EG, Hewitt D, Jensen MP, Katz NP, Kirkwood AA, Malamut R, Markman JD, Vrijens B, Burke L, Campbell JN, Carr DB, Conaghan PG, Cowan P, Doyle MK, Edwards RR, Evans SR, Farrar JT, Freeman R, Gilron I, Juge D, Kerns RD, Kopecky EA, McDermott MP, Niebler G, Patel KV, Rauck R, Rice ASC, Rowbotham M, Sessler NE, Simon LS, Singla N, Skljarevski V, Tockarshewsky T, Vanhove GF, Wasan AD, Witter J. Improving Study Conduct and Data Quality in Clinical Trials of Chronic Pain Treatments: IMMPACT Recommendations. J Pain 2020;21:931-42. [PMID: 31843583 DOI: 10.1016/j.jpain.2019.12.003] [Cited by in Crossref: 22] [Cited by in F6Publishing: 27] [Article Influence: 7.3] [Reference Citation Analysis]
23 Smith SM, Fava M, Jensen MP, Mbowe OB, Mcdermott MP, Turk DC, Dworkin RH. WITHDRAWN: Size Does Matter, But It Isn't Everything: The Challenge of Modest Treatment Effects in Chronic Pain Clinical Trials. The Journal of Pain 2019. [DOI: 10.1016/j.jpain.2019.09.008] [Reference Citation Analysis]
24 Agostinho M, Canaipa R, Honigman L, Treister R. No Relationships Between the Within-Subjects' Variability of Pain Intensity Reports and Variability of Other Bodily Sensations Reports. Front Neurosci 2019;13:774. [PMID: 31456655 DOI: 10.3389/fnins.2019.00774] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]